What is the current valuation of the UK Radio Pharmaceutical Market?

As of 2024, the UK Radio Pharmaceutical Market was valued at 0.383 USD Billion. Read More

What is the projected market valuation for the UK Radio Pharmaceutical Market in 2035?

The market is projected to reach a valuation of 0.916 USD Billion by 2035. Read More

What is the expected CAGR for the UK Radio Pharmaceutical Market during the forecast period?

The expected CAGR for the UK Radio Pharmaceutical Market from 2025 to 2035 is 8.26%. Read More

Which applications are driving growth in the UK Radio Pharmaceutical Market?

Key applications include Oncology, Cardiology, Neurology, Thyroid, and Infection, with Oncology projected to grow from 0.15 to 0.35 USD Billion. Read More

What types of products are included in the UK Radio Pharmaceutical Market?

The market includes Diagnostic, Therapeutic, Research, Radiopharmaceuticals, and Radioisotopes, with Diagnostic products expected to grow from 0.12 to 0.29 USD Billion. Read More

What are the primary end-use segments in the UK Radio Pharmaceutical Market?

End-use segments include Hospitals, Diagnostic Centers, Research Institutions, Pharmaceutical Companies, and Nuclear Medicine Departments. Read More

How much is the Oncology segment expected to grow by 2035?

The Oncology segment is expected to grow from 0.15 USD Billion in 2024 to 0.35 USD Billion by 2035. Read More

What is the growth outlook for the Cardiology segment in the UK Radio Pharmaceutical Market?

The Cardiology segment is projected to increase from 0.1 USD Billion in 2024 to 0.2 USD Billion by 2035. Read More

What is the significance of research institutions in the UK Radio Pharmaceutical Market?

Research Institutions are expected to see growth from 0.05 USD Billion in 2024 to 0.1 USD Billion by 2035, indicating their role in market expansion. Read More

UK Radiopharmaceuticals Market

Q: Who are the leading players in the UK Radio Pharmaceutical Market?

Key players include GE Healthcare, Bayer AG, Siemens Healthineers, Cardinal Health, and others. Read More

ID: MRFR/Pharma/63986-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

UK Radiopharmaceuticals Market Research Report: Size, Share, Trend Analysis By Types (Diagnostic, Therapeutic) and By Applications (Neurology, Cardiology, Oncology, Others) - Growth Outlook & Industry Forecast 2025 To 2035

UK Radiopharmaceuticals Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)8.26%

2024 Market Size$ 0.38 Billion

2025 Market Size$ 0.42 Billion

2035 Market Size$ 0.92 Billion

Key Players

GE Healthcare

Bayer AG

Siemens Healthineers

Cardinal Health

Elekta AB

Lantheus Medical Imaging

Trends

Technological Advancements in Imaging
Regulatory Support for Development
Focus on Personalized Medicine

Opportunities

Government Initiatives and Funding
Rising Awareness of Nuclear Medicine
Increasing Demand for Diagnostic Imaging

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Billion)
  1. 4.1.1 Oncology
  2. 4.1.2 Cardiology
  3. 4.1.3 Neurology
  4. 4.1.4 Thyroid
  5. 4.1.5 Infection
2. 4.2 Healthcare, BY Type (USD Billion)
  1. 4.2.1 Diagnostic
  2. 4.2.2 Therapeutic
  3. 4.2.3 Research
  4. 4.2.4 Radiopharmaceuticals
  5. 4.2.5 Radioisotopes
3. 4.3 Healthcare, BY End Use (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Centers
  3. 4.3.3 Research Institutions
  4. 4.3.4 Pharmaceutical Companies
  5. 4.3.5 Nuclear Medicine Departments
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 GE Healthcare (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Bayer AG (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Siemens Healthineers (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Cardinal Health (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Elekta AB (SE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Lantheus Medical Imaging (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Bracco Imaging S.p.A. (IT)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 NorthStar Medical Radioisotopes, LLC (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY TYPE
4. 6.4 UK MARKET ANALYSIS BY END USE
5. 6.5 KEY BUYING CRITERIA OF HEALTHCARE
6. 6.6 RESEARCH PROCESS OF MRFR
7. 6.7 DRO ANALYSIS OF HEALTHCARE
8. 6.8 DRIVERS IMPACT ANALYSIS: HEALTHCARE
9. 6.9 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 SUPPLY / VALUE CHAIN: HEALTHCARE
11. 6.11 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
12. 6.12 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
13. 6.13 HEALTHCARE, BY TYPE, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
17. 6.17 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY TYPE, 2026-2035 (USD Billion)
  3. 7.2.3 BY END USE, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Radiopharmaceuticals Market Segmentation

UK Radiopharmaceuticals Market By Application (USD Billion, 2026-2035)

Oncology
Cardiology
Neurology
Thyroid
Infection

UK Radiopharmaceuticals Market By Type (USD Billion, 2026-2035)

Diagnostic
Therapeutic
Research
Radiopharmaceuticals
Radioisotopes

UK Radiopharmaceuticals Market By End Use (USD Billion, 2026-2035)

Hospitals
Diagnostic Centers
Research Institutions
UK Radiopharmaceuticals Market Companies
Nuclear Medicine Departments

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”